Lee Fader

Lee Fader has extensive work experience in the pharmaceutical industry. Lee is currently the Vice President of Chemistry at Congruence Therapeutics since May 2021. Prior to that, they worked as an Associate Director at Ventus Therapeutics from January 2020 to March 2021. Lee also held the position of Associate Director at Inception Sciences, Inc. from April 2017 to January 2020. Before that, they worked as a Research Fellow I at Vertex Pharmaceuticals from June 2016 to February 2017. Lee Fader started their career at Boehringer Ingelheim in October 2004 as a Research Scientist, and they progressed to the roles of Senior Research Scientist from May 2010 to January 2013 and Principal Scientist from January 2013 to June 2016.

Lee Fader has a Doctor of Philosophy (Ph.D.) degree from McGill University. Prior to that, they obtained a Bachelor of Science (B.Sc.) degree from Concordia University. Lee Fader also pursued a NSERC PDF at ETH Zürich.